Corporate Mission Statement

AndroScience intends to use its expertise in natural product chemistry to discover proprietary compounds that target at different stages of the androgen activation pathway, and to develop lead compounds into new medicines for acne, androgenetic alopecia, wound healing, benign prostatic hyperplasia, prostate cancer and for other androgen or androgen receptor-related disorders.

NEWS & EVENTS

Updates for 2008

News & Updates for
ASC 2008...

 

Archives....

News & Updates for
September 2007...

News & Updates for
May and June...

News & Updates for
February and March...

AndroScience Corporation Enters Clinical Stage...

2006 News & Updates–
click here - Latest Announcements....

September 28, 2005 –
AndroScience Corporation’s abstract is accepted for
presentation at the 64th Annual Meeting of the American Academy of Dermatology, March 3-7, 2006

September 21-22, 2005,
RTA/Connect Venture Rountable,
September 12, 2005, AndroScience
Corporation today announced that it has been chosen to present
at RTA/Connect

July 20-24, 2005
American Academy
of Dermatology Conference,
 July 22, 2005 – AndroScience Corporation presented

May 27, 2005 Published in the San Diego Union Tribune Business Section - "People to Watch" - ASC's President & CEO....
http://www.signonsandiego.com/
uniontrib/20050527/
news_1b27people.html

March 21, 2005 UCSD
CONNECT
Financial Forum..
AndroScience Corporation Selected
 as a Finalist to Present
at 21st Annual
CONNECT Financial
Forum